Journal of Medicinal Chemistry · 2008 · 41 citations · 33 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryStructure-activity RelationshipsMarine Bioactive CompoundsMarine Drug DiscoveryBioactive Compounds From Marine FungiBioactive Compounds From Marine SpongesBioactive Marine MetabolitesMarine PharmacognosyMarine Sponge MetabolitesSecondary MetabolitesSponges As Drug SourcesSponges-derived Metabolites
This study involved a campaign to isolate and study additional latrunculin analogues from two taxonomically unrelated sponges, Cacospongia mycofijiensis and Negombata magnifica. A total of 13 latrunculin analogues were obtained by four different ways, reisolation (1-4), our repository (5, 6), new derivatives (7-12), and a synthetic analogue (7a). The structures of the new metabolites were elucidated on the basis of a combination of comprehensive 1D and 2D NMR analysis, application of DFT calculations, and the preparation of acetonide derivative 7a. The cytotoxicities against both murine and human cancer cell lines observed for 1, 2, 7, 7a, 8, 9, and 12 were significant, and the IC(50) range was 0.5-10 microM. Among the cytotoxic derivatives, compound 9 did not exhibit microfilament-disrupting activity at 5 microM. The implications of this observation and the value of further therapeutic study on key latrunculin derivatives are discussed.
33
Inhibition of actin polymerization by latrunculin A
Martine Coué, Stephen L. Brenner, Ilan Spector et al. · FEBS Letters · 1987 · 840 citations
Latrunculins: Novel Marine Toxins That Disrupt Microfilament Organization in Cultured Cells
Ilan Spector, Nava R. Shochet, Yoel Kashman et al. · Science · 1983 · 759 citations
Kathryn R. Ayscough, Joel Stryker, Navin Pokala et al. · The Journal of Cell Biology · 1997 · 741 citations · Full text